GBIO
Price
$0.44
Change
+$0.07 (+18.92%)
Updated
Jun 6 closing price
Capitalization
24.51M
59 days until earnings call
PRLD
Price
$1.03
Change
+$0.05 (+5.10%)
Updated
Jun 6 closing price
Capitalization
55.9M
66 days until earnings call
Interact to see
Advertisement

GBIO vs PRLD

Header iconGBIO vs PRLD Comparison
Open Charts GBIO vs PRLDBanner chart's image
Generation Bio
Price$0.44
Change+$0.07 (+18.92%)
Volume$1.7M
Capitalization24.51M
Prelude Therapeutics
Price$1.03
Change+$0.05 (+5.10%)
Volume$122.56K
Capitalization55.9M
GBIO vs PRLD Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. PRLD commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (GBIO: $0.37 vs. PRLD: $0.87)
Brand notoriety: GBIO and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 34% vs. PRLD: 196%
Market capitalization -- GBIO: $24.51M vs. PRLD: $55.9M
GBIO [@Biotechnology] is valued at $24.51M. PRLD’s [@Biotechnology] market capitalization is $55.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while PRLD’s TA Score has 4 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 2 bearish.
  • PRLD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than PRLD.

Price Growth

GBIO (@Biotechnology) experienced а -6.77% price change this week, while PRLD (@Biotechnology) price change was -4.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

PRLD is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($55.9M) has a higher market cap than GBIO($24.5M). PRLD YTD gains are higher at: -31.765 vs. GBIO (-65.415). GBIO has higher annual earnings (EBITDA): -74.26M vs. PRLD (-137.94M). GBIO has more cash in the bank: 185M vs. PRLD (134M). PRLD has less debt than GBIO: PRLD (18M) vs GBIO (93.6M). GBIO has higher revenues than PRLD: GBIO (19.9M) vs PRLD (7M).
GBIOPRLDGBIO / PRLD
Capitalization24.5M55.9M44%
EBITDA-74.26M-137.94M54%
Gain YTD-65.415-31.765206%
P/E RatioN/AN/A-
Revenue19.9M7M284%
Total Cash185M134M138%
Total Debt93.6M18M520%
TECHNICAL ANALYSIS
Technical Analysis
GBIOPRLD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 12 days ago
81%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bullish Trend 12 days ago
76%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 20 days ago
87%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
76%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-1.11%
CCCC - GBIO
48%
Loosely correlated
-3.08%
FHTX - GBIO
46%
Loosely correlated
+6.17%
IDYA - GBIO
46%
Loosely correlated
+0.72%
ATNM - GBIO
46%
Loosely correlated
-3.03%
ATXS - GBIO
45%
Loosely correlated
+6.85%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with MGTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+8.80%
MGTX - PRLD
36%
Loosely correlated
+0.20%
HUMA - PRLD
36%
Loosely correlated
+6.05%
GBIO - PRLD
36%
Loosely correlated
-1.11%
ITOS - PRLD
34%
Loosely correlated
+17.94%
VERV - PRLD
34%
Loosely correlated
-1.17%
More